Immunoprecise Antibodies Ltd (IPA) Stock Price, Quote & News

Company Profile

ImmunoPrecise Antibodies Ltd. operates as a techbio company. It leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies; and support the discovery and development of therapeutic antibodies. The company's contract research organizations services include B cell Select platforms that enable antibody screening directly from B cells, facilitating the analysis of a set of antibodies, as well as for screening compared to traditional t...

Industry: Biotechnology

Sector: Healthcare

Phone: (800) 620-4187

Website: www.ipatherapeutics.com

Address:

823 Congress Ave, Suite 300, Austin, United States

SadyK189 Jun. 17 at 12:59 AM

Top Stocks to watch tomorrow 2 / 2: $MVST $JVA $IPA $QSG $PACB MVST: Trending strongly on daily chart. Key support at 3.4 - 3.7. Looking good to test and break $5. Next key level at 5.30 - 5.60. IPA: Looking good on daily chart. Key support at 0.67 - 0.70. Next key level to test is 0.96 - 1. Currently at 0.82. JVA: Getting up on 4hours chart again. Key support at 3.70 - 4. Next key level to test is 5.25 - 5.50. Currently at 4.66. PACB: Looking good on daily chart. Key support at 1.05 - 1.15. Next key level to test is 1.70 - 1.85. It may take sometime though. Currently at 1.35. QSG: Looking good on daily chart. key support at 11.30 - 11.65. Next key level to test is 14.60 - 15.30. Currently at 13.19

0 · Reply

Onejoeshmoe Jun. 17 at 12:45 AM

$IPA this stock is 🔥🔥🔥🔥

0 · Reply

michaelburryburner Jun. 16 at 11:31 PM

$IPA after hours 🤣

0 · Reply

algo888 Jun. 16 at 10:59 PM

$IPA Told ya..

1 · Reply

NyseDayTrader Jun. 16 at 9:07 PM

$IPA This has to trade above $1 by august 18th for 10 days.. My money is on the company making this happen

1 · Reply

Chi2ggzz Jun. 16 at 8:49 PM

$IPA Bought this Friday at .74 then watched a very obvious manipulated drag down to .7 where structure kept buying /soaking and holding. Shorts are TRAPPED here lol

0 · Reply

22JS Jun. 16 at 8:36 PM

$IPA this one is nuts.. I have a bag of calls on it but it goes up 20 % and they hardly move.

1 · Reply

Breve99 Jun. 16 at 8:16 PM

$IPA Market maker is covering his recent short position. He still has shorts to cover. Lets go $IPA

0 · Reply

algo888 Jun. 16 at 8:05 PM

$IPA no penetration above .85 Im out

2 · Reply

WhatsUpWhatsNot Jun. 16 at 7:55 PM

$NVDA and $IPA certainly have my attention..

1 · Reply

AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation Studies

Jun 5, 2025, 8:01 AM EDT - 11 days ago

ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery

AMD

May 21, 2025, 8:49 AM EDT - 26 days ago

ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts

May 20, 2025, 8:28 AM EDT - 27 days ago

ImmunoPrecise Antibodies (IPA) to Present at Maxim Group's 2025 Virtual Tech Conference

May 12, 2025, 8:01 AM EDT - 5 weeks ago

IPA's LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed

AMD

Apr 11, 2025, 8:40 AM EDT - 2 months ago

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods

Mar 28, 2025, 12:59 PM EDT - 2 months ago

ImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call Transcript

Mar 28, 2025, 8:01 AM EDT - 2 months ago

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025

Mar 13, 2025, 7:02 AM EDT - 3 months ago

ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.

Mar 11, 2025, 10:17 PM EDT - 3 months ago

IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025

Mar 5, 2025, 8:01 AM EST - 3 months ago

IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025

Feb 26, 2025, 8:01 AM EST - 3 months ago

IPA and RIBOPRO Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy

Feb 24, 2025, 8:01 AM EST - 4 months ago

ImmunoPrecise Antibodies Announces Key Leadership Changes

Feb 20, 2025, 8:01 AM EST - 4 months ago

ImmunoPrecise Antibodies Announces Transfer to Nasdaq Capital Market and Extension of Bid Price Compliance Period

Jan 27, 2025, 8:01 AM EST - 5 months ago

ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture

Jan 22, 2025, 7:02 AM EST - 5 months ago

IPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes Treatment

Jan 17, 2025, 8:01 AM EST - 5 months ago

ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation

Dec 31, 2024, 7:56 PM EST - 5 months ago

IPA Announces Resignation of Chief Financial Officer

Dec 30, 2024, 10:03 PM EST - 6 months ago

$116 Million Multifamily Asset Sale in Central California Coast Region Brokered by Marcus & Millichap's Institutional Property Advisors

MMI

Dec 23, 2024, 8:30 AM EST - 6 months ago

ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share Purchases

Dec 19, 2024, 10:15 AM EST - 6 months ago

IPA to Present at The Microcap Conference 2025

Dec 10, 2024, 5:33 PM EST - 6 months ago

ImmunoPrecise Antibodies Ltd. (IPA) Q2 2025 Earnings Call Transcript

Dec 10, 2024, 8:30 AM EST - 6 months ago

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025

Dec 4, 2024, 8:00 AM EST - 6 months ago

IPA to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Dec 3, 2024, 8:30 AM EST - 6 months ago

IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 on December 10, 2024

Nov 13, 2024, 9:00 AM EST - 7 months ago

$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies

Nov 4, 2024, 8:01 AM EST - 8 months ago

ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation

Oct 28, 2024, 7:30 AM EDT - 8 months ago

ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology

Oct 21, 2024, 9:00 AM EDT - 8 months ago

ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024

Oct 16, 2024, 2:54 PM EDT - 8 months ago

Institutional Property Advisors Brokers $92.5 Million Multifamily Sale in L.A.'s NoHo Arts District

MMI

Oct 10, 2024, 8:10 AM EDT - 8 months ago

ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design

Oct 2, 2024, 8:00 AM EDT - 9 months ago

ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus

Sep 26, 2024, 9:00 AM EDT - 9 months ago

ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments

Sep 16, 2024, 1:46 PM EDT - 9 months ago

ImmunoPrecise Antibodies Ltd. (IPA) Q1 2025 Earnings Call Transcript

Sep 16, 2024, 9:00 AM EDT - 9 months ago

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025

Sep 9, 2024, 9:11 AM EDT - 10 months ago

IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024

Aug 26, 2024, 9:00 AM EDT - 10 months ago

ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York

Aug 23, 2024, 8:00 PM EDT - 10 months ago

ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements

Aug 19, 2024, 9:00 AM EDT - 10 months ago

ImmunoPrecise Antibodies Successfully Engineers in silico Antibodies to Elusive Tumor Protein Using Its Patented LENSai Technology

Jul 29, 2024, 8:36 PM EDT - 11 months ago

ImmunoPrecise Antibodies Ltd. (IPA) Q4 2024 Earnings Call Transcript

Jul 29, 2024, 8:30 AM EDT - 11 months ago

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024

Jul 23, 2024, 7:30 PM EDT - 11 months ago

ImmunoPrecise Antibodies to Reschedule Financial Results and Recent Business Highlights Report for Fourth Quarter and Fiscal Year-End 2024

Jul 16, 2024, 8:01 PM EDT - 11 months ago

ImmunoPrecise Announces Financing Agreement with Yorkville Advisors Global, LP of up to $3.0 Million Aggregate Principal Amount of Convertible Debentures

Jul 15, 2024, 8:31 AM EDT - 1 year ago

IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2024 on July 25th, 2024

Jun 27, 2024, 8:01 AM EDT - 1 year ago

ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer

Jun 25, 2024, 7:02 AM EDT - 1 year ago

IPA's Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai™

Jun 12, 2024, 7:00 AM EDT - 1 year ago

ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology

Jun 10, 2024, 7:15 AM EDT - 1 year ago

BioStrand, ImmunoPrecise Antibodies' Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug Discovery

Jun 4, 2024, 7:00 AM EDT - 1 year ago

IPA's Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR)

Apr 22, 2024, 9:00 AM EDT - 1 year ago

Epitope Binning Powered By LENSai TM Technology Can Analyze Over 5,000 Sequences With No Physical Materials Needed, Matches Classical Wet Lab Binning Results

SadyK189 Jun. 17 at 12:59 AM

0 · Reply

Onejoeshmoe Jun. 17 at 12:45 AM

$IPA this stock is 🔥🔥🔥🔥

0 · Reply

michaelburryburner Jun. 16 at 11:31 PM

$IPA after hours 🤣

0 · Reply

algo888 Jun. 16 at 10:59 PM

$IPA Told ya..

1 · Reply

NyseDayTrader Jun. 16 at 9:07 PM

$IPA This has to trade above $1 by august 18th for 10 days.. My money is on the company making this happen

1 · Reply

Chi2ggzz Jun. 16 at 8:49 PM

$IPA Bought this Friday at .74 then watched a very obvious manipulated drag down to .7 where structure kept buying /soaking and holding. Shorts are TRAPPED here lol

0 · Reply

22JS Jun. 16 at 8:36 PM

$IPA this one is nuts.. I have a bag of calls on it but it goes up 20 % and they hardly move.

1 · Reply

Breve99 Jun. 16 at 8:16 PM

$IPA Market maker is covering his recent short position. He still has shorts to cover. Lets go $IPA

0 · Reply

algo888 Jun. 16 at 8:05 PM

$IPA no penetration above .85 Im out

2 · Reply

WhatsUpWhatsNot Jun. 16 at 7:55 PM

$NVDA and $IPA certainly have my attention..

1 · Reply

Scofco Jun. 16 at 7:50 PM

$IPA Great day today! Let's keep this going all week!

0 · Reply

kozyman87 Jun. 16 at 7:49 PM

$IPA Bio Conference in Boston has begun, let’s get busy with Ai drug discovery discussions

1 · Reply

InstinctInvestor Jun. 16 at 7:46 PM

After hrs recap before market close $SRM $NCPL $IPA $URGN $SONM Watching these

1 · Reply

Stockttwits619 Jun. 16 at 7:45 PM

$GNLN $BW $TBH $SRM $IPA

0 · Reply

WhatsUpWhatsNot Jun. 16 at 7:41 PM

$IPA I didn’t think stocks like this are allowed to go up big on Mondays…thought only $AAP and $TSLA are allowed to go up big..curious.

0 · Reply

kozyman87 Jun. 16 at 7:37 PM

$IPA always worth revisiting a classic scene from “ The Big Short “ last two news about Ai discovered Dengue virus and GLP1 drugs mark a turning point in valuation

0 · Reply

teddiskim Jun. 16 at 7:19 PM

$IPA lotta new watchers here. welcome in yall

0 · Reply

algo888 Jun. 16 at 7:09 PM

$IPA Im dumbfounded traders are not jumping on this bandwagon ... Formation is very explicitly Bullish

1 · Reply

ShemimiTv Jun. 16 at 7:04 PM

Thoughts on these tickers? Watching for breakout setups: $LGCL $IPA

0 · Reply

algo888 Jun. 16 at 6:58 PM

$IPA Float relatively tiny @ 39.64 Million = Demand will soon go through the roof soon as it breaches above 1.00 - 1.07 range

0 · Reply

michaelburryburner Jun. 16 at 6:57 PM

$UAVS & $IPA running, up big early

1 · Reply

algo888 Jun. 16 at 6:54 PM

$IPA .90's incoming Then the re-entry from 1.00 to 1.07 chasing zone

0 · Reply

Market Cap	32.10M
Revenue (ttm)	18.16M
Net Income (ttm)	-20.13M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-110.85%
Debt to Equity Ratio	0.00

Volume	3,110,500
Avg Vol	1,975,968
Day's Range	N/A - N/A
Shares Out	45.77M
Stochastic %K	61%
Beta	0.12
Analysts	Strong Sell
Price Target	$4.00